We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $460.99 in the latest trading session, marking a +1.81% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 2.91% for the day. Elsewhere, the Dow gained 2.49%, while the tech-heavy Nasdaq added 3.83%.
Heading into today, shares of the company had lost 8.76% over the past month, outpacing the Medical sector's loss of 9.63% and lagging the S&P 500's loss of 7.64%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company's upcoming EPS is projected at $2.08, signifying a 14.92% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $2.61 billion, reflecting a 15.75% rise from the equivalent quarter last year.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $10.05 per share and revenue of $11.55 billion. These results would represent year-over-year changes of +12.54% and +14.76%, respectively.
Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.12% higher within the past month. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #3 (Hold).
With respect to valuation, Intuitive Surgical, Inc. is currently being traded at a Forward P/E ratio of 45.05. This expresses a premium compared to the average Forward P/E of 19.47 of its industry.
It's also important to note that ISRG currently trades at a PEG ratio of 2.87. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Instruments industry currently had an average PEG ratio of 2.08 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 103, this industry ranks in the top 43% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) closed at $460.99 in the latest trading session, marking a +1.81% move from the prior day. The stock fell short of the S&P 500, which registered a gain of 2.91% for the day. Elsewhere, the Dow gained 2.49%, while the tech-heavy Nasdaq added 3.83%.
Heading into today, shares of the company had lost 8.76% over the past month, outpacing the Medical sector's loss of 9.63% and lagging the S&P 500's loss of 7.64%.
The investment community will be closely monitoring the performance of Intuitive Surgical, Inc. in its forthcoming earnings report. The company's upcoming EPS is projected at $2.08, signifying a 14.92% increase compared to the same quarter of the previous year. At the same time, our most recent consensus estimate is projecting a revenue of $2.61 billion, reflecting a 15.75% rise from the equivalent quarter last year.
ISRG's full-year Zacks Consensus Estimates are calling for earnings of $10.05 per share and revenue of $11.55 billion. These results would represent year-over-year changes of +12.54% and +14.76%, respectively.
Any recent changes to analyst estimates for Intuitive Surgical, Inc. should also be noted by investors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.12% higher within the past month. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #3 (Hold).
With respect to valuation, Intuitive Surgical, Inc. is currently being traded at a Forward P/E ratio of 45.05. This expresses a premium compared to the average Forward P/E of 19.47 of its industry.
It's also important to note that ISRG currently trades at a PEG ratio of 2.87. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Instruments industry currently had an average PEG ratio of 2.08 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 103, this industry ranks in the top 43% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.